Snowball logo
logo
NVO_logo

Novo Nordisk A/S

$39.05-$0.38Β  (0.96%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
140,800176,954232,261290,403309,064329,431
COGS
23,65828,44835,76544,52258,78863,750
Gross Profit
117,142148,506196,496245,881250,276265,681
Operating Expenses & Income
Operating Income
58,64474,809102,574128,339127,658142,097
Total Operating Expenses
58,49873,69793,922117,542122,618123,584
R&D Expenses
17,77224,04732,44348,06252,03958,112
Selling General & Admin Expenses
4,0504,4674,8555,2765,9695,882
Earnings from Continuing Operations
Interest Expense
(289)(378)(542)(1,640)(4,207)(18,636.3)
Interest Income
5582391,0691,8382,88211,651
Income Tax Expense
11,32313,53720,99126,20328,10632,306
Net Income
Net Income
47,75755,52583,683100,988102,434116,443
Supplemental
EBIT
59,36969,440105,216128,831134,747153,748
EBITDA
65,39476,802114,629147,938156,729180,907
In millions of USD, except % and values per 1 share